114 related articles for article (PubMed ID: 18073772)
1. Spared caudal brainstem SERT binding in early Parkinson's disease.
Albin RL; Koeppe RA; Bohnen NI; Wernette K; Kilbourn MA; Frey KA
J Cereb Blood Flow Metab; 2008 Mar; 28(3):441-4. PubMed ID: 18073772
[TBL] [Abstract][Full Text] [Related]
2. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
Kish SJ; Tong J; Hornykiewicz O; Rajput A; Chang LJ; Guttman M; Furukawa Y
Brain; 2008 Jan; 131(Pt 1):120-31. PubMed ID: 17956909
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB).
Li Q; Ma L; Innis RB; Seneca N; Ichise M; Huang H; Laruelle M; Murphy DL
J Pharmacol Exp Ther; 2004 Feb; 308(2):481-6. PubMed ID: 14610240
[TBL] [Abstract][Full Text] [Related]
4. Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency.
Milak MS; Ogden RT; Vinocur DN; Van Heertum RL; Cooper TB; Mann JJ; Parsey RV
Biol Psychiatry; 2005 Jan; 57(1):102-6. PubMed ID: 15607307
[TBL] [Abstract][Full Text] [Related]
5. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease.
Guttman M; Boileau I; Warsh J; Saint-Cyr JA; Ginovart N; McCluskey T; Houle S; Wilson A; Mundo E; Rusjan P; Meyer J; Kish SJ
Eur J Neurol; 2007 May; 14(5):523-8. PubMed ID: 17437611
[TBL] [Abstract][Full Text] [Related]
6. Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter.
Strecker K; Wegner F; Hesse S; Becker GA; Patt M; Meyer PM; Lobsien D; Schwarz J; Sabri O
J Neurol; 2011 Jan; 258(1):19-26. PubMed ID: 20644949
[TBL] [Abstract][Full Text] [Related]
7. Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.
Sossi V; de la Fuente-Fernández R; Schulzer M; Troiano AR; Ruth TJ; Stoessl AJ
Ann Neurol; 2007 Nov; 62(5):468-74. PubMed ID: 17886297
[TBL] [Abstract][Full Text] [Related]
8. Serotonin Transporter Imaging in Multiple System Atrophy and Parkinson's Disease.
Chou KL; Dayalu P; Koeppe RA; Gilman S; Spears CC; Albin RL; Kotagal V
Mov Disord; 2022 Nov; 37(11):2301-2307. PubMed ID: 36102173
[TBL] [Abstract][Full Text] [Related]
9. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?
Kish SJ; Furukawa Y; Chang LJ; Tong J; Ginovart N; Wilson A; Houle S; Meyer JH
Nucl Med Biol; 2005 Feb; 32(2):123-8. PubMed ID: 15721757
[TBL] [Abstract][Full Text] [Related]
10. Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis.
Lee CS; Schulzer M; de la Fuente-Fernández R; Mak E; Kuramoto L; Sossi V; Ruth TJ; Calne DB; Stoessl AJ
Arch Neurol; 2004 Dec; 61(12):1920-5. PubMed ID: 15596613
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.
Jarkas N; Voll RJ; Williams L; Votaw JR; Owens M; Goodman MM
J Med Chem; 2008 Jan; 51(2):271-81. PubMed ID: 18085744
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the SERT binding densities in hypothalamus and amygdala in Cloninger type 1 and 2 alcoholics.
Storvik M; Haukijärvi T; Tupala E; Tiihonen J
Alcohol Alcohol; 2008; 43(1):25-30. PubMed ID: 18039673
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic dysregulation is linked to sleep problems in Parkinson's disease.
Wilson H; Giordano B; Turkheimer FE; Chaudhuri KR; Politis M
Neuroimage Clin; 2018; 18():630-637. PubMed ID: 29845011
[TBL] [Abstract][Full Text] [Related]
14. [¹⁸F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [¹⁸F]FDOPA and [¹¹C]DASB PET study in Parkinson's disease.
Pavese N; Simpson BS; Metta V; Ramlackhansingh A; Chaudhuri KR; Brooks DJ
Neuroimage; 2012 Jan; 59(2):1080-4. PubMed ID: 21963917
[TBL] [Abstract][Full Text] [Related]
15. Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.
Boileau I; Warsh JJ; Guttman M; Saint-Cyr JA; McCluskey T; Rusjan P; Houle S; Wilson AA; Meyer JH; Kish SJ
Mov Disord; 2008 Sep; 23(12):1776-80. PubMed ID: 18661545
[TBL] [Abstract][Full Text] [Related]
16. Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei: An ultra-high resolution PET-MRI study.
Kim JH; Son YD; Kim JH; Choi EJ; Lee SY; Joo YH; Kim YB; Cho ZH
Brain Res; 2015 Dec; 1629():63-71. PubMed ID: 26459992
[TBL] [Abstract][Full Text] [Related]
17. Brain serotonin transporter binding of [123I]ADAM: within-subject variation between summer and winter data.
Koskela A; Kauppinen T; Keski-Rahkonen A; Sihvola E; Kaprio J; Rissanen A; Ahonen A
Chronobiol Int; 2008 Sep; 25(5):657-65. PubMed ID: 18780196
[TBL] [Abstract][Full Text] [Related]
18. Serotonergic mediated body mass index changes in Parkinson's disease.
Politis M; Loane C; Wu K; Brooks DJ; Piccini P
Neurobiol Dis; 2011 Sep; 43(3):609-15. PubMed ID: 21624463
[TBL] [Abstract][Full Text] [Related]
19. Serotoninergic receptor 1A in the sudden infant death syndrome brainstem medulla and associations with clinical risk factors.
Machaalani R; Say M; Waters KA
Acta Neuropathol; 2009 Mar; 117(3):257-65. PubMed ID: 19052756
[TBL] [Abstract][Full Text] [Related]
20. Seasonal variation in human brain serotonin transporter binding.
Praschak-Rieder N; Willeit M; Wilson AA; Houle S; Meyer JH
Arch Gen Psychiatry; 2008 Sep; 65(9):1072-8. PubMed ID: 18762593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
